Antoine Legrand
Rennes, 35000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation.
Journal: International journal of molecular sciences
Published: November 29, 2022
Corrigendum to "Obesity III: Obesogen assays: Limitations, strengths, and new directions" [Biochem. Pharmacol. 199 (2022) 115014].
Journal: Biochemical pharmacology
Published: June 18, 2022
Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015].
Journal: Biochemical pharmacology
Published: June 17, 2022
Obesity II: Establishing causal links between chemical exposures and obesity.
Journal: Biochemical pharmacology
Published: December 20, 2021
Obesity III: Obesogen assays: Limitations, strengths, and new directions.
Journal: Biochemical pharmacology
Published: December 10, 2021
Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure.
Journal: Cell biology and toxicology
Published: August 31, 2021
Reply.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: February 12, 2019
Improving image quality of mid-trimester fetal sonography in obese women: role of ultrasound propagation velocity.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: August 29, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026